Comprised of 39 amino acids, Tirzepatide, a synthetic analog of the gastric inhibitory polypeptide (GIP), stands as a comparatively large peptide that appears to exert physiological potential through targeting and binding to GIP and GLP-1 (glucagon-like peptide-1)...
ACE-031 peptide is a soluble form of the type IIB activin receptor (ACVR2B), studied for its potential regulatory action on muscle growth. ACE-031 research suggests that the compound may have an extensive role in binding with and subsequently inactivating myostatin, a...
Liraglutide belongs to the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) class and is primarily researched for its potential influence in weight and insulin secretion. Researchers suggest Liraglutide may enhance glucose-dependent insulin secretion from...
B7-33 is a single-chain peptide, synthesized in a soluble form and derived from the naturally occurring protein H2-relaxin. This peptide appears to retain the anti-fibrotic properties of relaxin, reportedly without increasing cAMP production. B7-33 studies have...
ARA-290 is a synthetic 11-amino acid peptide developed to mimic erythropoietin’s structure and function (EPO). This hormone is considered to be a production regulator of red blood cells.(1) ARA-290 peptide is a non-erythropoietic peptide that researchers suggest...
Proxofim peptide, also known as FOXO4-DRI peptide, is a unique therapeutic peptide that has garnered attention recently due to its potential applications in reversing cell senescence. Studies have suggested that the Proxofim peptide may potentially counteract cellular...
